GlaxoSmithKline to Pay $3 Billion in Pharmaceutical Whistleblower Case

Pharmaceutical company GlaxoSmithKline has agreed to pay $3 billion in fines to the government in a pharmaceutical whistleblower case.  This is the largest pharmaceutical fraud settlement to date, and brings whistleblower lawsuit settlements to a total of $10 billion for 2012.  Whistleblowers get a share of these settlements as a reward for reporting fraud under the False Claims Act. The pharmaceutical whistleblowers were four GSK employees, including a vice president and a senior marketing development manager.  The pharmaceutical fraud involved GSK’s conduct regarding Paxil,...

read more

Whistleblower Reward of Nearly $21M for Health Plan Employee

  WellCare Health Plans employee blew the whistle on the managed care plan’s scheme to double bill Medicare and Medicaid for patient services.  The whistleblower was a senior financial analyst with WellCare, which provides managed care plans for 2.6 million people on Medicare and Medicaid.   The Tampa Bay Times explains the whistleblower reward:   Whistle-blowers who bring a lawsuit under the False Claims Act are entitled to receive a percentage of the recovery. Hellein’s award of $20.75 million represents his share of the $40 million in restitution received by the...

read more